Morphosys Extends Research Agreement with Pharma Firm Shionogi
November 11, 2011
Morphosys Extends Research Agreement with Pharma Firm Shionogi
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Bio-Rad Completes $70M Acquisition of AbD Serotec
January 10, 2013 / GenomeWeb Daily News - Morphosys Inks Deal with Moredun, Roslin to Develop Protein Reagents for Veterinary Research
October 21, 2011 / ProteoMonitor - Merck To Use Morphosys' HuCAL Gold Antibodies in Vaccine Research
August 5, 2011 / ProteoMonitor - Bio-Rad to Acquire AbD Serotec for $69.7M
December 17, 2012 / GenomeWeb Daily News - People in the News: Board Nominations at Vermillion and More
April 27, 2012 / ProteoMonitor